BrainChild Bio
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- Undisclosed
Investors
- 2
About BrainChild Bio
Based in the US, BrainChild Bio, Inc. offers a CAR-T platform designed for brain tumors to improve treatment outcomes for pediatric and adult central nervous system cancer patients. BrainChild Bio was established in 2023, founded by Michael Jensen, BrainChild Bio, Inc. In September 2026, BrainChild Bio, Inc. Steven Brugger is serving the role of CEO. BrainChild Bio develops cellular immunotherapies targeting central nervous system cancers. Its platform incorporates multiplexed targeting of tumor antigens, potency-enhancing technologies, and remote-control capabilities for CAR-T therapies. The company's initial clinical programs focus on pediatric brain tumors, with plans to expand into additional pediatric and adult CNS malignancies. BrainChild Bio is a clinical-stage biotechnology company. Revenue generation is expected to come primarily from future commercialization of approved cell therapies, strategic partnerships, licensing agreements, research collaborations, and potential milestone payments. Public sources reviewed do not disclose any current commercial revenue figures.
Who invested in BrainChild Bio
2 investors across 1 round
See all investors in BrainChild Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 8, 2026
Amount
Undisclosed
Investors
Questions about BrainChild Bio
Who invested in BrainChild Bio?
BrainChild Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BrainChild Bio raised?
BrainChild Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BrainChild Bio last raise money?
BrainChild Bio's most recent round on record is a Series A, in Sep 2026.
What does BrainChild Bio do?
Based in the US, BrainChild Bio, Inc.
Where is BrainChild Bio headquartered?
BrainChild Bio is headquartered in Seattle, US.
Which VCs invest in companies like BrainChild Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BrainChild Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BrainChild Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.